US PTAB IP Litigation
8,574 annotated decisions
Page 354 of 358 · 8,574 total
patent Final Written Decision
NEURENT MEDICAL INC. et al. v.The Foundry, LLC et al.
· IPR2024-00669
The Petitioner successfully demonstrated that multiple claims of the '077 patent were unpatentable over various combinations of prior art references. The Board found that a Person Having Ordinary Skill in the Art (POSA) would have been motivated to combine existing RF ablation and nasal treatment technologies.
patent Final Written Decision
Nintendo Co., Ltd. et al. v.American GNC Corporation
· IPR2024-00668
The PTAB issued a Final Written Decision finding claims 1 and 4 unpatentable over prior art combinations, specifically citing Smith/Chan/Bernstein and Tingleff/Chan/Bernstein. The Board maintained its construction that the 'micro inertial measurement unit' limitation requires MEMS implementation.
patent final
Nintendo Co., Ltd. et al. v.American GNC Corporation
· IPR2024-00667
The Board issued a Final Written Decision finding that claims 1 and 3 of patent 6508122 are unpatentable under 35 U.S.C. § 103(a). The Petitioner successfully demonstrated obviousness by combining multiple prior art references, including Fujiyoshi, Kumar, Cox, and Townsend.
patent Final Written Decision
Merck Sharp & Dohme LLC et al. v.The Johns Hopkins University
· IPR2024-00650
The PTAB issued a Final Written Decision finding all 38 claims of the '491 patent unpatentable. The Board construed "in response to" as requiring a causal link between MSI-H/dMMR determination and treatment, which led to a finding that the MSR anticipated and rendered obvious the challenged claims.
patent final
Roku, Inc. v.Intent IQ, LLC
· IPR2024-00666
The IPR petition against Intent IQ's '878 patent failed entirely, as the Board found no unpatentability for any challenged claim. The petitioner (Roku) argued obviousness over multiple prior art combinations related to targeted advertising using IP addresses.
patent final
Merck Sharp & Dohme LLC et al. v.The Johns Hopkins University
· IPR2024-00649
The PTAB found that the patent claims were unpatentable under both anticipation (35 U.S.C. § 102) and obviousness (35 U.S.C. § 103). The Board concluded that the MSI-H Study Record anticipates the claimed invention by teaching all elements, leading to a final decision against the patent owner.
patent final
Merck Sharp & Dohme LLC et al. v.The Johns Hopkins University
· IPR2024-00648
The PTAB found all 30 challenged claims unpatentable by anticipation (102) and obviousness (103). The Petitioner successfully argued that the MSI-H Study Record anticipates the claimed methods for treating non-colorectal MSI-H cancers.
patent final
Merck Sharp & Dohme LLC et al. v.The Johns Hopkins University
· IPR2024-00647
The PTAB found all 36 challenged claims unpatentable by both anticipation (35 U.S.C. § 102) and obviousness (35 U.S.C. § 103). The Board concluded that the MSI-H Study Record inherently anticipates the claimed methods, including those requiring pre-treatment testing for microsatellite instability high or DNA mismatch repair deficient status. This decision significantly weakens the patent's validity in the context of oncology and immunotherapy.
patent final
Aptiv Services US, LLC et al. v.Microchip Technology, Inc.
· IPR2024-00646
The PTAB found that the claims of the voltage regulator are unpatentable under § 103 based on a combination of Al-Shyoukh and Ivanov. The Board adopted Petitioner's interpretation of key terms, including finding 'gm enhanced' synonymous with 'gm boost.'
patent final
Under Armour, Inc. v.Athalonz, LLC
· IPR2024-00640
The PTAB issued a Final Written Decision finding all 15 challenged claims unpatentable by a preponderance of the evidence. The Petitioner successfully demonstrated that the claimed features were obvious in light of prior art references, particularly Won and Norton.
patent Final Written Decision
Under Armour, Inc. v.Athalonz, LLC
· IPR2024-00639
The Board issued a Final Written Decision finding all eight challenged claims unpatentable over various combinations of prior art. The Petitioner successfully demonstrated that the claimed features, including gradient compression and uniform heel platforms, were obvious in light of references like Umezawa, Gallas, Won, and Talarico '911. This outcome represents a significant loss for Athalonz, LLC regarding its footwear patent portfolio.
patent Final Written Decision
Under Armour, Inc. v.Athalonz, LLC
· IPR2024-00638
The Board issued a Final Written Decision finding all eleven challenged claims unpatentable. The core finding was that the claimed athletic shoe design was obvious over prior art references (Kim and De Obaldia).
patent final
Under Armour, Inc. v.Athalonz, LLC
· IPR2024-00637
The PTAB found the challenged claims of Athalonz unpatentable as obvious over prior art (Kim). The Board adopted a construction that allowed the petitioner (Under Armour) to satisfy claim limitations by measuring heights relative to the sole's bottom surface.
patent Final Written Decision
Fluidmaster, Inc. v.Danco, Inc. et al.
· IPR2024-00635
The PTAB panel majority found that the cited prior art references teach or suggest all limitations of claims 1-14, rendering them unpatentable under 35 U.S.C. § 103. The Board specifically construed key terms like 'overflow tube' and 'Flow Limitations' to support Petitioner’s reading, though ultimately found the overflow tube limitation was limiting in scope.
patent final
Under Armour, Inc. v.Athalonz, LLC
· IPR2024-00636
The PTAB issued a Final Written Decision finding all eight challenged claims unpatentable over the prior art reference Kim. The Board concluded that the synthetic rubber construction of Kim's golf shoe supports the existence of the claimed slopes, thereby establishing obviousness under 35 U.S.C. § 103.
patent final
Fluidmaster, Inc. v.Danco, Inc. et al.
· IPR2024-00633
The PTAB found several independent claims unpatentable over prior art references (Brown and Ho) using grounds of obviousness. The Board adopted a broad construction for 'integrally molded with' as 'molded together as a single structure.'
patent Final Written Decision
Fluidmaster, Inc. v.Danco, Inc. et al.
· IPR2024-00634
The PTAB found 16 claims unpatentable over prior art references, primarily based on obviousness (35 U.S.C. § 103). The Board upheld its construction of 'integrally molded with' as 'molded together as a single structure.'
patent Final Written Decision
Merck Sharp & Dohme LLC et al. v.The Johns Hopkins University
· IPR2024-00625
The PTAB issued a Final Written Decision finding that claims 1-8 of the patent were unpatentable. The Petitioner successfully demonstrated that the MSI-H Study Record (MSR) anticipates and renders obvious most challenged claims under both § 102 and § 103. The Board ruled that the Patent Owner's objective evidence of non-obviousness was insufficient to overcome these findings.
patent final
TESLA, INC. v.iQar Inc.
· IPR2024-00630
The PTAB found all 16 challenged claims unpatentable based on anticipation and obviousness. The decision hinged on the Petitioner successfully demonstrating that prior art (Koebler) disclosed all elements of the claimed invention, while also clarifying claim terms regarding sensor data analysis.
patent Final Written Decision
Merck Sharp & Dohme LLC et al. v.The Johns Hopkins University
· IPR2024-00623
The PTAB issued a Final Written Decision finding that all seven claims of the patent were unpatentable. The petitioner successfully demonstrated anticipation (102) and obviousness (103) based on the MSI-H Study Record, which was deemed prior art despite arguments regarding experimental use exceptions.
patent Final Written Decision
Merck Sharp & Dohme LLC et al. v.The Johns Hopkins University
· IPR2024-00624
The PTAB issued a Final Written Decision finding multiple claims of the '975 patent unpatentable. The petitioner successfully demonstrated that the claimed methods and drug characteristics were anticipated (102) or rendered obvious (103) by prior art, primarily the MSI-H Study Record (MSR).
patent Final Written Decision
Teladoc Health, Inc. v.Data Health Partners, Inc.
· IPR2024-00616
The PTAB issued a Final Written Decision finding that numerous claims of the patent were unpatentable based on obviousness. The Petitioner successfully demonstrated that various combinations of prior art references rendered the claimed features predictable to one skilled in the art.
patent final
Merck Sharp & Dohme LLC et al. v.The Johns Hopkins University
· IPR2024-00622
The PTAB found all 28 challenged claims unpatentable in this IPR proceeding concerning oncology/immunotherapy. The Petitioner successfully demonstrated that the MSI-H Study Record inherently anticipated or rendered obvious the claimed methods under both § 102 and § 103.
patent Final Written Decision
Ericsson Inc. et al. v.XR COMMUNICATIONS LLC
· IPR2024-00613
The PTAB issued a Final Written Decision rejecting the petitioner's contentions that the patent was unpatentable over Agee or in combination with Butler. The Board found Petitioner failed to meet its burden of proof, specifically regarding how prior art disclosed critical signal processing limitations.
